Abigail La Croix v. HHS - Tdap, cellulitis and shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On May 12, 2023, Abigail La Croix filed a petition alleging that a Tdap vaccination administered on April 1, 2022 caused cellulitis and a shoulder injury related to vaccine administration. The public stipulation also referenced a same-day COVID-19 vaccination, which is outside the Vaccine Program, and included a waiver and release of related CICP claims.
Ms. La Croix alleged both a Tdap-caused cellulitis injury and SIRVA-type shoulder injury lasting longer than six months.
Respondent denied that she suffered a Table SIRVA, denied that Tdap caused her shoulder injury, cellulitis, or any other injury, and denied vaccine-related sequelae. The public stipulation does not provide onset details, diagnostic findings, antibiotic or shoulder treatment, imaging, injections, therapy, or expert analysis.
On August 20, 2025, Chief Special Master Brian H. Corcoran adopted the parties' stipulation.
The total award was $89,400.00: $82,400.00 payable by ACH deposit to counsel's IOLTA account for prompt disbursement, and $7,000.00 payable to NYC HRA/DSS Liens and Recovery for a New York Medicaid lien. Ms.
La Croix was represented by Jeffrey S. Pop and Alexandra Pop.
Theory of causation
Tdap vaccine, April 1, 2022, adult exact age not stated, alleged cellulitis caused-in-fact and SIRVA; public stipulation also noted a same-day COVID-19 vaccine outside the VICP and a CICP waiver/release. COMPENSATED by stipulation for total $89,400: $82,400 by ACH to counsel's IOLTA account and $7,000 New York Medicaid lien to NYC HRA/DSS Liens and Recovery. Respondent denied Table SIRVA, Tdap causation, and vaccine-related sequelae. Chief Special Master Corcoran, August 20, 2025. Attorneys Jeffrey S. Pop and Alexandra Pop.
Source PDFs
USCOURTS-cofc-1_23-vv-00711